Accovion GmbH expands global presence in Spain

Monday, June 25, 2012 10:31 AM

Accovion GmbH, a full-service provider of clinical development services based in Eschborn, Germany, has launched an additional subsidiary in Spain.

The subsidiary’s main office in Madrid has opened and is complemented by a regional presence in Barcelona. Together with Poland, Russia, Romania, Czech Republic and U.K., Accovion is now able to present itself with six subsidiaries in total, which further emphasizes the international growth of the company. With its expansion, Accovion aims to offer its clients a broader spectrum of country-specific clinical research expertise providing the quality services that Accovion is known for.

With the expansion, Verónica de Lázaro Vettorello was appointed country director of Spain at Accovian, taking over the business activities in the country.

"Spain represents a key strategic territory for Accovion. When it comes to conducting clinical trials in Europe, Spain is among the top five within Europe,” explained Lázaro Vettorello. "Another important aspect is that the majority of our clients conduct clinical trials in Spain. The country has a very well-established clinical research scenery, excellently educated clinical research professionals (e.g. Spanish association of CROs) and well-known medical hospital quality.”

She added, “Together we will pursue Accovion’s successful development and will further increase our international market share of high value clinical development services.”

Share:          
CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs